Clinical trial
Combination Chemotherapy in Treating Women With Stage III Breast Cancer
NCT00002696 · Grupo Oncologico Cooperativo del Sur, Other · Suspended
Key facts
| NCT number | NCT00002696 |
|---|---|
| Title | Combination Chemotherapy in Treating Women With Stage III Breast Cancer |
| Official title | MULTIMODALITY TREATMENT STRATEGY FOR STAGE III BREAST CANCER |
| Lead sponsor | Grupo Oncologico Cooperativo del Sur, Other |
| Status | Suspended |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | CAF regimen, CMF regimen, cyclophosphamide, doxorubicin hydrochloride, fluorouracil, methotrexate, adjuvant therapy, conventional surgery, neoadjuvant therapy, radiation therapy |
| Start date | Oct 1, 1995 |
| First posted | Jan 27, 2003 |
| Last update posted | Aug 2, 2013 |
| Countries | Argentina |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: